openPR Logo
Press release

Hormone Replacement Therapy Market Outlook 2026: Key Vendors, Growth Factors And Market Share Forecast Offered In Latest Report Estmated By Global Players Novartis Ag, Abbott Laboratories, Mylan N.V., Merck Kgaa, Bayer Ag, Pfizer Inc.

03-15-2019 01:10 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Global Hormone Replacement Therapy Market

Global Hormone Replacement Therapy Market

New mergers and acquisitions is one of the major factor driving the growth of the hormone replacement therapy market. For instance, in 2014 Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has an orphan drug designation in the U.S. and Europe for adults and children with growth hormone deficiency.

For In depth Information Get Sample Copy of this Report at:

Robust pipeline is also expected to support growth of the hormone replacement therapy market size. For instance, Somapacitan sponsored by Novo Nordisk A/S, a Denmark-based company, completed phase 3 clinical trials in 2017. This drug is used for the treatment of growth hormone deficiency in adults.

The global hormone replacement therapy market size was valued at US$ 10.58 billion in 2017 and is expected to witness a CAGR of 5.2% over the forecast period (2018 – 2026).

Market Dynamics:

Increasing number of people suffering from hypogonadism and rising adoption of testosterone products in various economies is expected to propel overall growth of the market. According to the data published in the European Association of Urology Journal: 2017, testosterone prescription trends in the U.S. exhibited an increase between 1.8- and 4-fold over the last two decades (1997 - 2017). Moreover, from 2000 to 2011, there was a 4.3-fold increase in testosterone testing when compared to a 3.7-fold increase in prescriptions.
Rising number of generic versions of hormone replacement therapies by various manufacturers will drive growth of the market in terms of volume and value. For instance, Teva Pharmaceutical Industries Ltd. launched the generic Axiron1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.S. on August 18, 2017 to treat adult males who have low or no testosterone due to certain medical conditions. This solution was supplied in a metered dose pump with an underarm applicator.

However, high cost associated with the replacement therapy and complex reimbursement scenario that causes excluding of the therapy from coverage by insurers, as it is a rare disease, hampers growth of the hormone replacement therapy market.

Increasing prevalence of various chronic conditions are expected to drive growth of the hormone replacement therapy market:

Increasing prevalence of hypogonadism in adult men worldwide is expected to drive growth of the hormone replacement therapy market.

According to the European Association of Urology: 2016 report, in middle-aged men, the incidence of hypogonadism varies from 2.1% to 12.8%. The incidence of low testosterone and symptoms of hypogonadism in men aged 40-79 varies form 2.1% to 5.7%, in Europe.
Ease in access and government support for research and development activities is expected to aid in growth of the hormone replacement therapy market. Financial help by NGOs such as the National Gaucher Society help patients receive enzyme replacement therapy that are costly.

Hormone Replacement Therapy Market - Regional Insights:

On the basis of region, the global hormone replacement therapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the global hormone replacement therapy market, owing to continuous launch of various generic products for hormone replacement therapies by manufacturers.
Furthermore, Europe is expected to be the second largest contributor to the hormone replacement therapy market, in terms of revenue and is expected to gain significant traction in the near future. This is owing to launch of new drugs and therapies to combat secondary hyperparathyroidism and presence of significant population suffering from the disease in this region.

For instance, in December 2016, Amgen’s drug etecalcetide (Parsabiv) received marketing approval in Europe by the European Commission for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney diseases.
Asia Pacific is expected to witness fastest growth over the forecast period, owing to increasing healthcare associated issues with rising incidence of chronic diseases, high prevalence of hypogonadism in men with type II diabetes mellitus, and rising prevalence of diabetes population in this region.

For instance, according to the International Diabetes Federation (IDF) Diabetes Atlas: 2017, number of people suffering from diabetes aged between 20 to 79 years in South East Asia region and Western Pacific region in 2017, was 82 million and 159 million, respectively.

Browse Research Report At:

Global Key Players:

Key players operating in the global hormone replacement therapy market include
Novartis AG
Abbott Laboratories
Mylan N.V.
Merck KgaA
Bayer AG
Pfizer Inc.
Novo Nordisk A/S
QuatRx Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Amgen, Inc.
Eli Lilly and Company.

Detailed Segmentation:

Global Hormone Replacement Therapy Market, By Therapy Type:
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy

Global Hormone Replacement Therapy Market, By Route of Administration:

Global Hormone Replacement Therapy Market, By Application:
Male Hypogonadism
Growth Hormone Deficiency

Global Hormone Replacement Therapy Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Hormone Replacement Therapy Market, By Region:
North America
Asia Pacific
Latin America
Middle East

Ask For Discount Before Purchasing This Business Report @

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below linkor contact at

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hormone Replacement Therapy Market Outlook 2026: Key Vendors, Growth Factors And Market Share Forecast Offered In Latest Report Estmated By Global Players Novartis Ag, Abbott Laboratories, Mylan N.V., Merck Kgaa, Bayer Ag, Pfizer Inc. here

News-ID: 1657047 • Views: 352

More Releases from Coherent Market Insights

Training Market World's Top Players Include Skillsoft Limited, Safety Media, GP …
The global training market was valued at US$ 94,828.5 Mn in 2017 and is expected to exhibit a CAGR of 6.4% over the forecast period and reach US$ 174,596.6 Mn in 2027. North America accounted for 45.1% of the revenue share in the global training market in 2018. The Asia Pacific market is witnessing high growth due to increasing demand for cost effective learning management solutions. Moreover, an increase in
5G Infrastructure Market To Witness Double Digit Cagr By 2027
5G is a key enabler for the futuristic digital world. It offers ultra-high broadband infrastructure, for application in various sectors such as healthcare, automotive, and manufacturing. Increasing number of connected devices plays a key role in growth of the 5G infrastructure market. For In depth Information Get Sample Copy of this Report @ Software-Defined Networking segment is projected to account for the dominant position in global 5G infrastructure market over
Semiconductor IP Market Top Keyplayers Arm, Synopsys, Cadence, Imagination, Latt …
A semiconductor Intellectual Property (IP) is a logic unit or logic chip that can be reused and is an intellectual property of a circuit. This IP is used in integrated circuit designs or field-programmable gate array (FPGA) logic designs as building blocks. Semiconductor intellectual property enables faster chip design by using existing blocks. It is also responsible for improving the quality of any device, in turn enhancing the efficiency of
Online Marketing Place for Hospitality Services Market Top Keyplayers Hotwire, H …
The desktop platform holds a dominant position in the global online marketing place for hospitality services market, whereas, the mobile platform is expected to grow with the largest CAGR over the forecast period, owing to increasing popularity of mobile apps and mobile-based websites. In addition to this, the increasing number of smart phone users is a major factor providing swift growth to the mobile platform of this market. Online Marketing

All 12046 Releases

More Releases for Therapy

Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Proton therapy market
Global Proton therapy market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). Proton therapy is the most precise and advanced form of radiation therapy and is mainly used in the treatment of cancer. It
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
RARE 24k Therapy Creme
Introducing Rare 24k Therapy: When NSAIDS, toxic pain killers, chiropractors and heating pads aren’t giving you enough, add RARE 24K Therapy Crème to your doctor prescribed regime. A new, natural, and scientifically proven, gold skincare remedy that delivers non-toxic pain relief to people suffering with arthritis, muscle strains, or joint pain. Press Release – December 2016 SALT LAKE CITY - RARE, 24k Gold Therapy Crème offers deep therapeutic relief using newly
Injectable Targeted Therapy Market
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of
Physical Therapy Knee Exercises
Of all orthopedic problems, knee pain is probably the most common. While the causes for knee pain are many, strengthening the knee muscles through proper exercise is one of the most effective ways to protect them from pain and injury. Physical therapy knee exercises recommended by a qualified and experienced physical therapist can help restore physical strength and motion following a knee surgery or injury. These exercises help reduce recovery